References

10.1016/s0013-7006(04)95427-9 · 2004 · Admitted local publication

Enantiomeric antidepressant drugs should be considered on individual merit

10.1002/hup.336 · 2001 · External reference

Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors

10.1038/sj.bjp.0705800 · 2004 · External reference

Characterization of an allosteric citalopram-binding site at the serotonin transporter

10.1111/j.1471-4159.2004.02835.x · 2005 · External reference

The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors

10.1016/j.euroneuro.2004.08.008 · 2005 · External reference

Adult hippocampal neurogenesis as target for the treatment of depression

10.2174/187152707780619353 · 2007 · External reference

Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain

10.1038/sj.npp.1300686 · 2005 · External reference

Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies

10.1017/s1461145705006462 · 2007 · External reference

Mechanisms of action of antidepressants: new data from Escitalopram

2003 · External reference

Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder

10.1097/yic.0b013e3280128d16 · 2007 · External reference

Long-term adaptive changes induced by serotonergic antidepressant drugs

10.1586/14737175.6.2.235 · 2006 · External reference

Escitalopram prevents relapse of obsessive-compulsive disorder

10.1016/j.euroneuro.2006.11.005 · 2007 · External reference

Serotonin uptake and serotonin uptake inhibition

10.1111/j.1749-6632.1990.tb16873.x · 1990 · External reference

Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials

10.1016/j.jad.2004.11.011 · 2005 · External reference

Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine

10.1097/00004850-199512004-00003 · 1995 · External reference

Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants

10.1074/jbc.m505055200 · 2006 · External reference

The pharmacological effect of citalopram residues in the (S)- (+) –enantiomer

10.1007/bf01244820 · 1992 · External reference

Escitalopram and citalopram: the unexpected role of the R-enantiomer

10.1016/s0013-7006(07)91548-1 · 2007 · External reference

Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis

10.1097/01.yic.0000194375.42589.c3 · 2006 · External reference

Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats

10.1038/sj.mp.4000954 · 2001 · External reference

L’escitalopram dans le traitement des épisodes dépressifs majeurs de l’adulte

10.1016/s0013-7006(05)82410-8 · 2005 · External reference

Deep brain stimulation for treatment-resistant depression

10.1016/j.neuron.2005.02.014 · 2005 · External reference

R-citalopram prevents the neuronal adaptive changes induced by escitalopram

10.1097/wnr.0b013e3282f04047 · 2007 · External reference

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model

10.1034/j.1600-0773.2001.d01-118.x · 2001 · External reference

The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats

10.1016/s0028-3908(03)00138-2 · 2003 · External reference

10.1002/da.20207

10.1002/da.20207 · External reference

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

10.1016/s0006-3223(01)01145-3 · 2001 · External reference

The stereochemical mechanism of the cooperative effects in hemoglobin revisited

10.1146/annurev.biophys.27.1.1 · 1998 · External reference

High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions

10.1016/j.neulet.2005.04.028 · 2005 · External reference

R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model

2003 · External reference

R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram

10.1016/j.pbb.2003.12.001 · 2004 · External reference

Escitalopram versus citalopram: the surprising role of the R-enantiomer

10.1007/s00213-004-1865-z · 2004 · External reference

The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram

10.1111/j.1742-7843.2006.pto_295.x · 2006 · External reference

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

10.1126/science.1083328 · 2003 · External reference

Ago-allosteric modulation and other types of allostery in dimeric 7TM receptors

10.1080/10799890600567570 · 2006 · External reference

Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050

10.1016/j.ejphar.2006.10.004 · 2007 · External reference

Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans

10.1002/(sici)1520-636x(1997)9:7<686::aid-chir9>3.0.co;2-5 · 1997 · External reference

Allosteric modulation of G protein-coupled receptors: perspectives and recent developments

10.1016/s1359-6446(04)03220-9 · 2004 · External reference

R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter

10.1038/sj.bjp.0705738 · 2004 · External reference

R-citalopram decreases the association of [3H]-S-citalopram with the human serotonin transporter by an allosteric mechanism

10.1016/s0924-977x(03)91811-6 · 2003 · External reference